Immunization, HepB3 in Libya
Libya: Immunization, HepB3 was 86.0% in 2024. ▼ Falling
Immunization, HepB3 in Libya, 1992–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
Libya recorded 86.0% for immunization, hepb3 in 2024.
That represents a change of up 17.8% on the previous year and down 8.5% over ten years.
Over the whole period, immunization, hepb3 in Libya peaked at 99.0% in 2004 and was at its lowest, 73.0%, in 2018.
That places Libya 118th out of 188 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 33 years of available data.
Immunization, HepB3 in Libya, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1992 | 88.0% | — |
| 1993 | 91.0% | +3.4% |
| 1994 | 92.0% | +1.1% |
| 1995 | 92.0% | +0.0% |
| 1996 | 93.0% | +1.1% |
| 1997 | 91.0% | -2.2% |
| 1998 | 92.0% | +1.1% |
| 1999 | 92.0% | +0.0% |
| 2000 | 92.0% | +0.0% |
| 2001 | 93.0% | +1.1% |
| 2002 | 91.0% | -2.2% |
| 2003 | 96.0% | +5.5% |
| 2004 | 99.0% | +3.1% |
| 2005 | 97.0% | -2.0% |
| 2006 | 98.0% | +1.0% |
| 2007 | 98.0% | +0.0% |
| 2008 | 98.0% | +0.0% |
| 2009 | 98.0% | +0.0% |
| 2010 | 98.0% | +0.0% |
| 2011 | 98.0% | +0.0% |
| 2012 | 98.0% | +0.0% |
| 2013 | 96.0% | -2.0% |
| 2014 | 94.0% | -2.1% |
| 2015 | 97.0% | +3.2% |
| 2016 | 97.0% | +0.0% |
| 2017 | 97.0% | +0.0% |
| 2018 | 73.0% | -24.7% |
| 2019 | 73.0% | +0.0% |
| 2020 | 73.0% | +0.0% |
| 2021 | 73.0% | +0.0% |
| 2022 | 73.0% | +0.0% |
| 2023 | 73.0% | +0.0% |
| 2024 | 86.0% | +17.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 91.4% | 88.0% | 93.0% | 8 |
| 2000s | 96.0% | 91.0% | 99.0% | 10 |
| 2010s | 92.1% | 73.0% | 98.0% | 10 |
| 2020s | 75.6% | 73.0% | 86.0% | 5 |
Countries ranked near Libya
- 118 Czechia 86.0% compare
- 118 Dominican Republic 86.0% compare
- 118 Grenada 86.0% compare
- 118 Lesotho 86.0% compare
- 118 Mauritania 86.0% compare
- 118 Niger 86.0% compare
- 118 Switzerland 86.0% compare
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Heat deaths vs projected death rates 1,084 (2090)
- Un projection of annual infant deaths 133 (2100)
- Population ages 0-14, total, annual growth rate -1.03 % change on previous year (2025)
- Population ages 0-14, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, total, per capita 0.2685 units per person (2025)
- Population ages 15-64, female, annual growth rate 1.65 % change on previous year (2025)
- Population ages 15-64, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 15-64, female, per capita 0.333 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in Libya?
- Immunization, hepb3 in Libya was 86.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Libya?
- The highest recorded value was 99.0% in 2004.
- What is the lowest immunization, hepb3 recorded in Libya?
- The lowest recorded value was 73.0% in 2018.
- How does Libya rank for immunization, hepb3?
- Libya ranks 118th out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in Libya?
- Over the last ten years it is down 8.5%. The long-run trend across the full record is falling.
- Where does this Libya data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.